These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10815360)

  • 21. The health utility of mild and severe dysphonia.
    DeVore EK; Shrime MG; Wittenberg E; Franco RA; Song PC; Naunheim MR
    Laryngoscope; 2020 May; 130(5):1256-1262. PubMed ID: 31381164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in patients with uveitis.
    Shamdas M; Bassilious K; Murray PI
    Br J Ophthalmol; 2019 Sep; 103(9):1284-1288. PubMed ID: 30361275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation.
    Matza LS; Boye KS; Feeny DH; Bowman L; Johnston JA; Stewart KD; McDaniel K; Jordan J
    Eur J Health Econ; 2016 Nov; 17(8):979-990. PubMed ID: 26611792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is it going to be, TTO or SG? A direct test of the validity of health state valuation.
    Lipman SA; Brouwer WBF; Attema AE
    Health Econ; 2020 Nov; 29(11):1475-1481. PubMed ID: 32744408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming inherent problems of preference-based techniques for measuring health benefits: an empirical study in the context of kidney transplantation.
    Kontodimopoulos N; Niakas D
    BMC Health Serv Res; 2006 Jan; 6():3. PubMed ID: 16412242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity, feasibility and acceptability of time trade-off and standard gamble assessments in health valuation studies: a study in a multiethnic Asian population in Singapore.
    Wee HL; Li SC; Xie F; Zhang XH; Luo N; Feeny D; Cheung YB; Machin D; Fong KY; Thumboo J
    Value Health; 2008 Mar; 11 Suppl 1():S3-10. PubMed ID: 18387064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The standard gamble showed better construct validity than the time trade-off.
    Puhan MA; Schünemann HJ; Wong E; Griffith L; Guyatt GH
    J Clin Epidemiol; 2007 Oct; 60(10):1029-33. PubMed ID: 17884597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients.
    Sharma S; Brown GC; Brown MM; Hollands H; Robins R; Shah GK
    Br J Ophthalmol; 2002 May; 86(5):493-6. PubMed ID: 11973240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom.
    Guest JF; Nanuwa K; Barden R
    Health Qual Life Outcomes; 2014 Jun; 12():89. PubMed ID: 24917331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health values of patients with systemic sclerosis.
    Khanna D; Ahmed M; Furst DE; Ginsburg SS; Park GS; Hornung R; Tsevat J
    Arthritis Rheum; 2007 Feb; 57(1):86-93. PubMed ID: 17266070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility assessment among cataract surgery patients.
    Saw SM; Gazzard G; Gomezperalta C; Au Eong KG; Seah S
    J Cataract Refract Surg; 2005 Apr; 31(4):785-91. PubMed ID: 15899457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The utility of hand transplantation in hand amputee patients.
    Alolabi N; Chuback J; Grad S; Thoma A
    J Hand Surg Am; 2015 Jan; 40(1):8-14. PubMed ID: 25534832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HYE (healthy years equivalent) and TTO (time trade-off): what is the difference?
    Morrison GC
    J Health Econ; 1997 Oct; 16(5):563-78. PubMed ID: 10175631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of individual and collective decision making for standard gamble and time trade-off.
    Attema AE; Bleichrodt H; l'Haridon O; Lipman SA
    Eur J Health Econ; 2020 Apr; 21(3):465-473. PubMed ID: 31902024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?
    Boye KS; Matza LS; Feeny DH; Johnston JA; Bowman L; Jordan JB
    Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):437-50. PubMed ID: 24832003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic methods for measuring the quality of life associated with HIV infection.
    Bayoumi AM; Redelmeier DA
    Qual Life Res; 1999 Sep; 8(6):471-80. PubMed ID: 10548862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are QALYs based on time trade-off comparable?--A systematic review of TTO methodologies.
    Arnesen T; Trommald M
    Health Econ; 2005 Jan; 14(1):39-53. PubMed ID: 15386674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of methods for converting DCE values onto the full health-dead QALY scale.
    Rowen D; Brazier J; Van Hout B
    Med Decis Making; 2015 Apr; 35(3):328-40. PubMed ID: 25398621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility values in the visually impaired: comparing time-trade off and VisQoL.
    Gothwal VK; Bagga DK
    Optom Vis Sci; 2013 Aug; 90(8):843-54. PubMed ID: 23628757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.